You have read all your free articles, to continue reading subscribe to read the rest of this content.
Bioarctic Neuroscience has announced that the first patients in Sweden have been treated with BAN2401 in a clinical study for patients with an early type of Alzheimer's disease. BAN2401 is a monoclonal antibody that has been developed in the laboratory of Professor Lars Lannfeldt at Uppsala UniveAlready a subscriber Login…
Novo Nordisk announced a new analysis of phase 3 data demonstrating people with hemophilia A who had the highest annualized bleeding rate (ABR) during initial treatment with NovoEight® (turoctocog alfa) showed the largest reduction in bleeding over the duration of treatment. Data for the recombinaAlready a subscriber Login You have read…
The company has announced positive results from the dose optimisation study CONDUCT, which is evaluating cobitolimod for the treatment of moderate to severe ulcerative colitis. The study met the primary endpoint of clinical remission, demonstrating a superior efficacy of 15% (delta) in patients rAlready a subscriber Login You have read…
Medivir communicates an update on the status of the development of JNJ-4178, the triple combination of simeprevir, odalasvir and AL-335, following The International Liver Congress 2017 of the European Association for the Study of the Liver (EASL), which was held in Amsterdam, on 19-23 April. DataAlready a subscriber Login You…
